Unit: Payer Research & Market Access Consulting
Indication: Preeclampsia
Subject: Market access options & reimbursement for a diagnostic test (section 135, 137c, 137e SGB V)
Target group: Federal Joint Committee (G-BA), Association of Statutory Health Insurance Physicians, statutory health insurance funds, hospital controlling
Method: Individual telephone interviews, analysis, text summary
Sample: N = 4
Year: 2013